STOCK TITAN

Bayer Aktien Stock Price, News & Analysis

BAYRY OTC

Welcome to our dedicated page for Bayer Aktien news (Ticker: BAYRY), a resource for investors and traders seeking the latest updates and insights on Bayer Aktien stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bayer Aktien's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bayer Aktien's position in the market.

News
Rhea-AI Summary

On March 6, 2023, Research and Markets announced the release of the "Robot Report Subscription: Market Shares, Market Strategies, and Market Forecasts, 2022 to 2028" by Wintergreen Research, enhancing its offerings. The subscription includes access to seven reports focusing on various robotics sectors, promising automation to bolster industrial efficiency across diverse fields. Key markets include collaborative robots in automotive and manufacturing, as well as agricultural and security robots. The report highlights substantial growth potential, driven by the shift towards electric vehicles and automation in repetitive tasks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
none
-
Rhea-AI Summary

Leverage IP has appointed Robert A. Matthews, Jr. as its new U.S. patent-law expert, bringing over 30 years of legal experience. Matthews will advise clients on various patent-related issues, enhancing Leverage IP's service offerings in managing legal challenges and litigation. His background includes significant work at top law firms and authorship of the Annotated Patent Digest, a highly regarded resource in patent law. The consultancy aims to support businesses through the entire IP lifecycle, leveraging its expertise to help clients maximize the value of their innovations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
none
-
Rhea-AI Summary

Nachawati Law Group has strengthened its mass torts practice by welcoming veteran attorney Brian McMath. With previous experience as senior counsel for the New Mexico Office of the Attorney General, McMath led significant litigation against opioid manufacturers, achieving nearly $480 million in settlements. His background also includes lawsuits against tech companies for violations of online privacy laws, securing approximately $8 million for children's technology initiatives. The firm, recognized for its work on cases involving PFAS contamination and cancer-related products, aims to enhance its representation of public entities through McMath's expertise.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
Rhea-AI Summary

The global market for Insecticidal Seed Treatment is projected to grow from $4.5 Billion in 2022 to $9.2 Billion by 2030, achieving a CAGR of 9.2% during this period. The U.S. market is estimated at $1.2 Billion, while China is expected to reach $2 Billion with a CAGR of 12.9%. The report highlights growing trends, including increased food demand due to a rising population and the effects of global warming on pest prevalence. However, 2023 poses challenges such as inflation, economic slowdown, and potential recession, impacting market dynamics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
-
Rhea-AI Summary

The global biorational market is projected to reach USD 29.93 billion by 2032, growing at a CAGR of 20.7%. This growth is driven by the increasing demand for biorational therapies in crop production to combat pests effectively. Biorationals, including biological pesticides, are noted for their environmental safety and low toxicity to humans. The report highlights that botanicals will dominate revenue shares, with fruits and vegetables leading demand. Moreover, Asia Pacific is experiencing the fastest revenue growth, largely due to rising consumer demand in China and India.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
-
Rhea-AI Summary

Consumer Edge has appointed Mitch Barns to its Board of Directors, effective immediately. Barns, former CEO of Nielsen, brings extensive experience in data and analytics, aligning well with Consumer Edge's growth vision. His tenure at Nielsen included managing over $6 billion in revenue. The appointment follows a recent equity financing round that raised over $60 million from CoVenture, aimed at bolstering the company’s growth initiatives. Consumer Edge specializes in consumer insights and analytics to enhance strategic decision-making for stakeholders in diverse corporate landscapes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
management
Rhea-AI Summary

Corteva, Inc. (NYSE: CTVA) reported its fourth quarter and full-year 2022 results, highlighting net sales of $3.83 billion for Q4, a 10% increase year-over-year. However, the company faced a loss from continuing operations of $(41) million for Q4 and $1.22 billion for FY 2022, reflecting declines of 33% and 32% respectively. Full-year net sales rose 11% to $17.46 billion, with an operating EBITDA of $3.22 billion and operating EPS of $2.67. Guidance for 2023 estimates net sales between $18.1 billion and $18.4 billion, marking a 5% growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
-
Rhea-AI Summary

Salesforce (NYSE: CRM) announced new appointments to its Board of Directors, effective March 1, 2023.

  • Arnold Donald, former President and CEO of Carnival Corporation
  • Sachin Mehra, CFO of Mastercard
  • Mason Morfit, CEO of ValueAct Capital

This move is part of Salesforce's strategy for board refreshment aimed at enhancing leadership. Outgoing directors Sanford Robertson and Alan Hassenfeld will not seek re-election. CEO Marc Benioff welcomed the new members, highlighting their diverse expertise to foster continued growth for Salesforce, a company valued at approximately $150 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
management
-
Rhea-AI Summary

Bayer has appointed Ben Kampelman, previously Director of Strategic Communications for Crop Science North America, as the new Vice President of Communications for the Crop Science division in North America. In this role, Kampelman will oversee all corporate communications activities, focusing on corporate reputation and media relations. With over 20 years of experience at Bayer and its predecessor Monsanto, he brings extensive industry knowledge. This leadership change is expected to enhance Bayer's communication strategies in North America, supporting its vision of Health for All, Hunger for None. Kampelman assumed his role in November 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
management
Rhea-AI Summary

ONIT Sciences announced that Eric Mathur, a distinguished plant geneticist and molecular biologist, has been appointed as the company’s Chief Science Officer. With over 40 years of experience, Mathur has expertise in genome sciences, molecular biology, and agricultural biotechnology. He aims to enhance ONIT's research and development efforts and has already initiated field trials to optimize the company’s products for various applications, including cattle ranching. ONIT Sciences, founded in 2018, focuses on increasing crop yield and plant health through organic technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Bayer Aktien (BAYRY)?

The current stock price of Bayer Aktien (BAYRY) is $7.93 as of September 26, 2025.

What is the market cap of Bayer Aktien (BAYRY)?

The market cap of Bayer Aktien (BAYRY) is approximately 33.2B.
Bayer Aktien

OTC:BAYRY

BAYRY Rankings

BAYRY Stock Data

33.21B
3.93B
0.59%
Drug Manufacturers - General
Healthcare
Link
Germany
Leverkusen